Abstract: The invention relates to compositions and methods containing hemp and/or cannabis-derived cannabidiol (CBD) for topical use in treating female sexual dysfunction induced by antidepressants, including, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin/norepinephrine reuptake inhibitors (SNRIs), and other anti-depressants.
Type:
Application
Filed:
June 16, 2023
Publication date:
October 26, 2023
Applicant:
VELLA BIOSCIENCE, INC.
Inventors:
Harin Padma-Nathan, MIchael Frid, Helen Segil, Nial Chase DeMena
Abstract: The invention relates to compositions and methods containing hemp and/or Cannabis-derived cannabidiol (CBD) for topical use in treating female sexual dysfunction induced by antidepressants, including, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin/norepinephrine reuptake inhibitors (SNRIs), and other anti-depressants.
Type:
Grant
Filed:
February 2, 2021
Date of Patent:
August 8, 2023
Assignee:
Vella Bioscience, Inc.
Inventors:
Harin Padma-Nathan, MIchael Frid, Helen Segil, Nial Chase DeMena
Abstract: The invention relates to compositions and methods containing hemp and/or cannabis-derived cannabidiol (CBD) for topical use in treating female sexual dysfunction induced by antidepressants, including, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin/norepinephrine reuptake inhibitors (SNRIs), and other anti-depressants.
Type:
Application
Filed:
February 2, 2021
Publication date:
September 16, 2021
Applicant:
VELLA BIOSCIENCE, INC.
Inventors:
Harin Padma-Nathan, MIchael Frid, Helen Segil, Nial Chase DeMena